BioVie Inc. (BIVI) Social Stream



BioVie Inc. (BIVI): $0.49

0.01 (-1.42%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add BIVI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#215 of 359

in industry

BIOVIE INC (BIVI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BIVI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-05-24 1 $50 $50 $50 $1.28 3806.25%
2021-11-30 1 $27 $27 $27 $1.28 2009.38%
2022-01-21 1 $18 $18 $18 $1.28 1306.25%
2022-05-16 2 $18 $9 $13.5 $1.28 954.69%
2022-07-22 3 $18 $7 $11.333 $1.28 785.39%
2022-09-12 3 $12 $7 $9.333 $1.28 629.14%
2022-09-28 3 $12 $7 $9 $1.28 603.12%
2023-04-05 4 $12 $7 $9.75 $1.28 661.72%
2023-04-11 4 $12 $8.001 $10.75 $1.28 739.84%
2023-08-21 3 $12 $8.001 $10.333 $1.28 707.27%
2023-11-09 2 $12 $11 $11.5 $1.28 798.44%
2023-11-30 2 $5 $5 $5 $1.28 290.62%

The Trend in the Analyst Price Target


BIVI's average price target has moved down $42 over the prior 33 months.

BIVI reports an average of 131.59% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-06 4 12 7.000 9.750 8.76 11.3%
2023-04-11 3 12 8.001 10.750 7.80 37.82%
2023-04-11 3 12 8.001 10.333 7.80 32.47%
2023-04-11 4 12 8.001 10.750 7.80 37.82%
2023-05-16 3 12 8.001 10.333 6.99 47.83%

BIVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 30 months, BIVI's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, BIOVIE INC's upside potential (average analyst target price relative to current price) is greater than 1442.29% of them.
  • In the context of all US stocks, BIOVIE INC's number of analysts covering the stock is greater than 88.3% of them.
  • BIOVIE INC's variance in analysts' estimates is lower than -220.21% of Pharmaceutical Products stocks.
  • In the context of Healthcare stocks, BIOVIE INC's average analyst price target is greater than 349.66% of them.

Stocks similar to BIOVIE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GLSI, GLTO, and OLMA.

Is BIVI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!